Kiora Pharmaceuticals Income Statement (2015-2025) | KPRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) -1.92M0.23M0.27M0.16M0.18M0.15M0.07M1.10M0.24M0.31M2.69M0.01M-686.00-0.00M-0.00M-937.0016.00M
Operating items
Research & Development (Quarter) 0.32M0.60M0.41M1.38M0.91M2.48M2.45M2.58M1.81M2.26M3.18M3.08M2.52M1.84M2.26M1.44M0.72M0.76M2.41M1.50M0.94M0.63M0.99M1.01M1.28M1.44M1.63M1.00M0.71M0.57M1.33M0.44M1.39M1.09M1.11M0.19M1.14M0.87M0.74M1.97M1.68M1.66M1.75M
Selling, General & Administrative (Quarter) 0.78M0.94M0.95M1.29M1.53M1.58M1.20M1.28M1.29M1.21M1.04M1.10M0.95M1.20M1.23M1.05M1.14M1.11M1.05M1.12M1.03M1.09M1.02M1.51M1.30M1.31M1.34M1.38M1.66M1.80M2.03M1.27M1.10M1.42M0.88M1.30M1.54M1.38M1.33M1.49M1.35M1.44M1.46M
Other Operating Expenses (Quarter) -2.00M-2.22M6.34M-2.00M0.07M0.07M3.99M0.18M0.27M0.95M0.21M0.14M3.42M0.13M1.29M-0.11M1.35M0.50M-1.13M-0.64M-2.31M4.10M
Operating Expenses (Quarter) 1.10M1.54M1.35M2.68M2.44M4.06M3.65M3.86M3.10M3.48M4.21M4.17M3.48M3.04M3.49M2.49M1.86M1.87M3.45M2.62M1.97M1.72M2.01M1.18M2.01M2.82M3.04M6.37M3.57M2.40M3.70M1.92M2.63M5.92M2.12M2.78M2.56M3.60M2.56M2.33M2.40M0.79M7.31M
Operating Income (Quarter) -2.80M-1.54M-1.36M-2.44M-3.83M-3.38M-2.92M-3.33M-4.14M-2.38M-2.80M-3.18M0.83M-1.87M-3.45M-1.97M-1.72M-2.01M-1.17M-2.01M-2.82M-3.04M-6.37M-3.57M-2.40M-3.70M-1.92M-2.63M-5.92M-2.12M13.22M-2.54M-3.60M-2.56M-2.33M-2.40M-0.79M-7.31M
EBIT (Quarter) -2.80M-1.54M-1.36M-2.44M-3.83M-3.38M-2.92M-3.33M-4.14M-2.38M-2.80M-3.18M0.83M-1.87M-3.45M-1.97M-1.72M-2.01M-1.17M-2.01M-2.82M-3.04M-6.37M-3.57M-2.40M-3.70M-1.92M-2.63M-5.92M-2.12M13.22M-2.54M-3.60M-2.56M-2.33M-2.40M-0.79M-7.31M
Non-operating items
Interest & Investment Income (Quarter) 163.000.00M202.00326.00317.000.00M298.00261.00261.00236.0040.0027.0026.000.02M0.05M0.05M0.04M0.03M0.02M0.01M0.02M0.00M331.00224.00250.00332.00259.00300.00217.000.00M0.05M0.05M0.05M0.22M0.34M0.25M0.44M0.28M0.23M0.20M0.19M
Other Non Operating Income (Quarter) 10.00-0.00M1.000.28M937.000.01M-0.03M0.11M-0.07M0.01M-0.02M-0.06M0.10M-0.02M-0.09M-0.02M-0.03M
Non Operating Income (Quarter) 10.00-0.00M-0.01M317.000.00M298.00-14.00-42.00-69.00-264.00-276.00-278.000.02M0.05M0.05M0.04M0.03M0.02M0.01M0.02M0.00M331.00-0.00M-436.000.28M259.00-0.00M937.000.05M0.02M0.11M-0.06M0.01M-0.02M-0.06M0.10M-0.02M0.13M0.18M-0.73M
Net income details
EBT (Quarter) -4.72M-1.54M-1.36M-2.44M-3.82M-3.38M-2.92M-3.33M-4.14M-2.38M-2.78M-3.12M0.87M-1.84M-3.43M-1.95M-1.72M-2.01M-1.17M0.57M-2.47M-3.03M-14.39M-3.57M-2.40M-3.70M-1.92M-2.59M-5.87M-2.08M13.45M-2.22M-3.41M-2.16M-2.07M-2.26M-0.62M-7.17M
Tax Provisions (Quarter) 2.07M0.12M-0.11M-0.64M-0.67M
Profit After Tax (Quarter) -2.80M-1.54M-1.36M-2.69M-2.44M-3.82M-3.38M-3.70M-2.92M-3.33M-4.14M-2.83M-2.38M-2.78M-3.12M-2.53M0.87M-1.84M-3.43M-2.70M-1.95M-1.72M-2.01M-1.19M-2.01M-2.54M-3.03M-6.18M-3.57M-2.40M-5.12M-1.87M-2.61M-5.76M-2.27M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.52M
Income from Non-Controlling Interests (Quarter) -0.01M-0.03M-1.51
Income from Continuing Operations (Quarter) -4.72M-1.54M-1.36M-2.44M-3.82M-3.38M-2.92M-3.33M-4.14M-2.38M-2.78M-3.12M0.87M-1.84M-3.43M-1.95M-1.72M-2.01M-1.17M0.57M-2.47M-3.03M-14.39M-3.57M-2.40M-3.70M-1.92M-2.59M-5.87M-2.08M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.50M
Consolidated Net Income (Quarter) -4.72M-1.54M-1.36M-2.44M-3.82M-3.38M-2.92M-3.33M-4.14M-2.38M-2.78M-3.12M0.87M-1.84M-3.43M-1.95M-1.72M-2.01M-1.17M0.57M-2.47M-3.03M-14.39M-3.57M-2.40M-3.70M-1.92M-2.59M-5.87M-2.08M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.50M
Income towards Parent Company (Quarter) -4.72M-1.54M-1.36M-2.44M-3.82M-3.38M-2.92M-3.33M-4.14M-2.38M-2.78M-3.12M0.87M-1.84M-3.43M-1.95M-1.72M-2.01M-1.17M0.57M-2.47M-3.03M-14.39M-3.57M-2.40M-3.70M-1.92M-2.59M-5.87M-2.08M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.50M
Preferred Dividend Payments (Quarter) 8.22M0.53M
Net Income towards Common Stockholders (Quarter) -11.03M-1.54M-1.36M-2.69M-2.44M-3.82M-3.38M-3.70M-2.92M-3.33M-4.14M-2.38M-2.78M-3.12M0.87M-1.84M-3.43M-1.95M-1.72M-2.01M-1.17M0.57M-2.47M-3.03M-14.39M-3.57M-2.40M-3.70M-1.92M-2.59M-6.40M-2.08M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.52M
Additional items
EPS (Basic) (Quarter) -3.23-0.24-0.19-0.24-0.31-0.46-0.36-0.38-0.28-0.28-0.24-0.15-0.14-0.07-1.08-0.770.30-0.63-1.15-0.76-0.43-0.38-0.44-0.24-0.37-0.35-11.34-21.43-11.27-0.18-6.03-1.00-7.15-7.30-0.904.67-0.53-0.81-1.15-0.52-0.540.01-1.56
EPS (Weighted Average and Diluted) (Quarter) -0.140.19-0.43-0.44-0.24-0.37-0.35-11.34-21.43-11.27-0.18-6.03-1.00-7.15-7.30-0.903.46-0.53-0.81-1.04-0.52-0.540.01-1.60
Shares Outstanding (Weighted Average) (Quarter) 3.42M4.90M7.16M6.16M7.85M8.11M9.27M8.83M10.46M12.07M13.27M14.26M17.26M27.43M2.18M2.37M2.92M2.92M2.98M3.18M4.52M4.54M4.55M4.59M7.36M7.41M0.27M0.24M0.32M13.06M0.50M1.86M0.29M0.79M0.54M2.88M3.53M4.21M3.87M4.22M3.99M4.29M4.17M
Shares Outstanding (Diluted Average) (Quarter) 17.26M4.50M4.52M4.55M4.59M7.36M7.47M0.21M0.24M0.32M13.06M0.85M1.86M0.37M0.44M0.54M3.89M4.17M4.21M4.13M4.22M3.94M4.36M4.10M
EBITDA (Quarter) -2.72M-1.51M-1.36M-2.70M-2.44M-3.82M-3.38M-3.70M-2.92M-3.32M-4.14M-2.83M-2.38M-2.78M-3.12M-2.53M0.87M-1.84M-3.43M-2.70M-1.95M-1.72M-2.02M-1.31M-2.01M-2.82M-3.08M-6.21M-3.54M-2.57M-5.16M-1.90M-2.62M-5.80M-2.19M13.37M-2.20M-3.24M-4.43M-2.21M-2.10M0.03M-6.52M
Interest Expenses (Quarter) 1.92M0.01M275.00303.00305.00304.00303.00304.00304.00304.00128.00108.00108.00109.000.00M686.000.00M0.00M937.000.01M
Tax Rate (Quarter) -95.67%-5.94%4.95%104.35%9.32%